Hippo
-
The next generation must stay private longer, employ a partnership approach to capital and take the complexities of insurance more seriously.
-
Stock prices fluctuated, and InsurTech short-sellers took some profits.
-
The InsurTech’s stock traded at $28.25 by midday Tuesday, down from its $163.93 peak in February 2021.
-
InsurTechs, including Lemonade, Root, Hippo, and Metromile, shed some short interest but remain the target of choice for short-sellers.
-
The partnership should allow Hippo to expand its commercial lines HOA product into new markets.
-
Lemonade, Root, and Metromile remain the focus of short sellers, as most firms see little short interest change.
-
Lemonade and Root remain the focal points of short sellers, while Metromile’s stock loan fee rate increases (pending acquisition).
-
The Week in Brief: FM Global’s vaccine mandate, Hippo on going public, Hagerty SPAC deal redemptionsInside P&C’s news team runs you quickly through the key developments from the last week.
-
Richard McCathron said that Metromile’s fate does not concern him because InsurTechs are not made equal.
-
Just over a quarter of shareholders voted to redeem shares as Aldel Financial took classic car underwriter public.
-
Short interest fell in InsurTechs, but not enough to ease the pressure on the sector.
-
Everyone knows the phrase “A jack of all trades is a master of none.” Relatively few people know the continuation of the phrase: “but often times better than a master of one.”
Most Recent
-
Walmart ordered to pay injured worker $34.7mn for defamation
November 25, 2024 -
Daily Digest: Top news from November 22
November 22, 2024 -
Cyberattacks on supply chain up 431% since 2021: Cowbell
November 22, 2024